SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Patel Chem Specialities Ltd (544460) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 544460 NSE: | Chemicals | Small Cap

Patel Chem Specialit Share Price

85.76 -1.79 (-2.04%)
As on 17-Apr'26 16:59

Patel Chem Specialities Ltd (544460)

BSE: 544460 NSE:
Key Metrics
Market Cap
₹213 Cr.
P/E Ratio
20.19
Price to Book (P/B)
2.26
Price to Sales (P/S)
2.03
EV/EBITDA
14.46
Return on Capital Employed (ROCE)
35.23%
Current Price
₹85.8
Return on Equity (ROE)
38.47%
Return on Assets (ROA)
18.82%
Operating Profit Margin
14.5%
Net Profit Margin
10.05%
Gross Profit Margin
14.1%
Book Value per Share
₹37.9
Sales Growth (YoY)
27.6%
Sales Growth (3 Years)
20.22%
Operating Profit Growth (1 Year)
30.85%
Operating Profit Growth (3 Years)
50.72%
Net Profit Growth (1 Year)
37.99%
52-Week Low / High
₹56 / 121
Net Profit Growth (3 Years)
66.74%
Dividend Yield
0.00%
Promoter Holding
68.36%
Pledged shares (%)
of Promoter's holding (%)
0.00%

Check Before You Invest

Q.1 Revenue growth of Patel Chem Specialities Ltd?
Patel Chem Specialities Ltd revenue growth is 27.6% for FY-2025 , which is above its 5 year CAGR of 0% , indicating faster growth.
Q.1 Promoter shareholding and pledge status of Patel Chem Specialities Ltd?
Promoters hold 68.36% of the Patel Chem Specialities Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Revenue growth of Patel Chem Specialities Ltd vs industry peers?
Patel Chem Specialities Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 7.7% , indicating stable growth and maintaining its market share.
Q.1 Which industry/sub-sector does Patel Chem Specialities Ltd belong to?
Patel Chem Specialities Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.
Q.1 Stock return of Patel Chem Specialities Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

DeciZen - make an informed investing decision on Patel Chem Specialit

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation

Overvalued

3. Price Trend

Weak

Patel Chem Specialities stock performance

Key Ratios
mw4me loader

Is Patel Chem Specialities Ltd an attractive stock to invest in?

1. Is Patel Chem Specialities Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Patel Chem Specialities Ltd is a below average quality company.

2. Is Patel Chem Specialities Ltd undervalued or overvalued?

The key valuation ratios of Patel Chem Specialities Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Patel Chem Specialities Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Patel Chem Specialities Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Patel Chem Specialities Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 24.7%26%38.7%35.2%-
Value Creation
Index
0.80.91.81.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 60.569.482.4105105
Sales YoY Gr.-14.8%18.7%27.6%-
Adj EPS 1.31.64.45.84.3
YoY Gr.-20.6%178.5%32.5%-
BVPS (₹) 5.3711.519.837.9
Adj Net
Profit
2.22.77.510.411
Cash Flow from Ops. 2.126.11.9-
Debt/CF from Ops. 3.762.57.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA20.2%27.6%
Adj EPS NANA64.5%32.5%
BVPSNANA55.4%72.4%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
24.825.847.73814.7
Op. Profit
Mgn %
7.47.914.214.5NAN
Net Profit
Mgn %
3.73.99.19.910.1
Debt to
Equity
0.910.80.4-
Working Cap
Days
0951181190
Cash Conv.
Cycle
04054640

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 20.22%

Net Profit is growing at healthy rate in last 3 years 64.49%

Debt to equity has declined versus last 3 years average to 0.42

Return on Equity has declined versus last 3 years average to 14.70%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials

Standalone Consolidated
TTM EPS (₹) 4.3 -
TTM Sales (₹ Cr.) 105 -
BVPS (₹) 37.9 -
Reserves (₹ Cr.) 69 -
P/BV 2.26 -
PE 20.19 -
From the Market
52 Week Low / High (₹) 56.10 / 120.89
All Time Low / High (₹) 56.10 / 120.89
Market Cap (₹ Cr.) 213
Equity (₹ Cr.) 24.9
Face Value (₹) 10
Industry PE 45.3

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Patel Chem Specialit - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales606982105
Operating Expenses + 56647190
Manufacturing Costs3477
Material Costs49555774
Employee Cost 2234
Other Costs 2335
Operating Profit 451215
Operating Profit Margin (%) 7.4%7.9%14.2%14.5%
Other Income + 0000
Exceptional Items 0000
Interest 1111
Depreciation 0111
Profit Before Tax 441014
Tax 1134
Profit After Tax 23811
PAT Margin (%) 3.8%4.2%9.3%10.1%
Adjusted EPS (₹)1.31.74.55.9
Dividend Payout Ratio (%)0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 9122035
Share Capital 11118
Reserves 8111918
Debt +8121515
Long Term Debt3578
Short Term Debt4697
Minority Interest0000
Trade Payables512810
Others Liabilities 2245
Total Liabilities 23374765

Fixed Assets

Net Fixed Assets +10141414
Gross Block13171818
Accumulated Depreciation3345
CWIP 00212
Investments 0000
Inventories271012
Trade Receivables10151521
Cash Equivalents 1011
Others Assets 1255
Total Assets 23374765

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 2262
PBT 441014
Adjustment 1111
Changes in Working Capital -2-2-4-10
Tax Paid -0-1-1-3
Cash Flow From Investing Activity + -4-3-6-7
Capex -5-4-3-11
Net Investments 0000
Others 21-33
Cash Flow From Financing Activity + 0105
Net Proceeds from Shares 0005
Net Proceeds from Borrowing 1211
Interest Paid -1-1-1-1
Dividend Paid 0000
Others 0-0-0-0
Net Cash Flow -1-000

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)25.3727.6848.7838.47
ROCE (%)24.7225.9738.7435.23
Asset Turnover Ratio2.582.291.961.87
PAT to CFO Conversion(x)10.670.750.18
Working Capital Days
Receivable Days58656763
Inventory Days10223739
Payable Days35546346

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Patel Chem Specialities Ltd FAQs

The current trading price of Patel Chem Specialit on 17-Apr-2026 16:59 is ₹85.76.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Patel Chem Specialit stood at ₹213.3 Cr

The latest P/E ratio of Patel Chem Specialit as of 16-Apr-2026 is 20.19.

The latest P/B ratio of Patel Chem Specialit as of 16-Apr-2026 is 2.26.

The 52-week high of Patel Chem Specialit is ₹120.9 and the 52-week low is ₹56.10.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Patel Chem Specialit is ₹105 ( Cr.) .

About Patel Chem Specialities Ltd

Patel Chem Specialities Limited was originally incorporated on June 25, 2008, as a private limited company as ‘Patel Chem Specialities Private Limited’ under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Pursuant to a special resolution passed by the Shareholders at their Extra ordinary General Meeting held on July 4 2024, the company was converted from a private limited company to public limited company and consequently, the name of the company was changed to ‘Patel Chem Specialities Limited’ and a fresh Certificate of Incorporation consequent to conversion was issued on August 29, 2024, by the Registrar of Companies, Central Processing Centre.

The company operates in the field of specialty chemicals, particularly focusing on the production of cellulose-based excipients. It manufactures a diverse range of products that are critical to various industries, including pharmaceuticals, food & beverages, cosmetics, and numerous industrial applications. These chemicals are fundamental in the formulation of essential products such as tablets, food additives, personal care items, and industrial formulations. Its products play vital roles as binders, disintegrants, thickeners, stabilizers, and gelling agents, each serving a specialized function across multiple sectors.

Since inception, the company manufactures Carboxymethyl Cellulose Sodium (Sodium CMC), Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose Calcium (CMC Calcium), Croscarmellose Sodium (CCS), Sodium Starch Glycollate (SSG), and Sodium Monochloro Acetate (SMCA). With a commitment to quality and innovation, it has successfully established a strong global presence, exporting its products to many countries, including the USA, Germany, UK, Japan, China, Australia, and many more. Its expertise in producing high-quality excipients has enabled it to carve out a niche in the cellulose-based chemicals market, driven by its adherence to international quality standards such as US-DMF, GMP, ISO 9001:2015 etc.

The company offers a diverse range of cellulose-based chemicals, each serving specialized functions across various industries. Sodium CMC, a versatile product, is used as a thickener, binder, and gelling agent in pharmaceuticals, food & beverages, cosmetics, and industrial applications such as oil drilling, under the brand ‘Rheollose’. Microcrystalline Cellulose (MCC) is valued in pharmaceuticals and food & beverages as a bulking agent, texturizer, and binder, with products branded as ‘Hindcel’. Sodium Starch Glycollate (SSG) serves as a disintegrant in tablets, available in corn (BlowTab C) and potato-based (BlowTab P) variants. Croscarmellose Sodium and Calcium CMC, powerful super disintegrants, are marketed as Disolwell and 'Swellcal’, respectively.

Business area of the company

The company is one of the leading manufacturing companies in chemical based on caustic soda flaks, maize, methanol and manufacturing CMC, SSG and other types of similar material mainly used pharma, food and other chemical industries.

Products of the company

  • Sodium Monochloro Acetate (SMCA)
  • Blowtab - Sodium Starch Glycolate (SSG)
  • Disolwell - Croscaremellose Sodium (CCS)
  • Swellcal - Carboxymethyl Cellulose Calcium (Calcium CMC)
  • Rheollose - Sodium Carboxymethyl Cellulose (Sodium CMC)
  • Hindcell - Microcrystalline Cellulose (MCC)

History and milestones

  • 2008: Incorporation of the Company.
  • 2021: Company acquired a land at Indrad, Mahesana, with an area of 9,409 square meters.
  • 2022: Company acquired a Talod Unit (Land and, Plant and Machinery), Himmatnagar, with an area of 6,767 square meters.
  • 2022: Crossed Rs 50 crore revenue.
  • 2023: Recognized as One Star Export House.
  • 2023: Received MSME ZED Bronze Certificate.
  • 2024: The company was converted from a private limited company into a public limited company.
  • 2025: Vatva Unit is registered as US-FDA approved facility.

You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×